JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB282566

Human LMOD1 knockout SH-SY5Y cell line

Be the first to review this product! Submit a review

|

(0 Publication)

LMOD1 KO cell line available to order. KO validated by. Free of charge wild type control provided.

View Alternative Names

1D, 64 kDa autoantigen 1D, 64 kDa autoantigen 1D3, 64 kDa autoantigen D1, 9530015K06Rik, D1, LMOD1_HUMAN, Leiomodin, Leiomodin-1, SM-Lmod, Smooth muscle leiomodin, Thyroid-associated ophthalmopathy autoantigen, muscle form

1 Images
Sanger Sequencing - Human LMOD1 knockout SH-SY5Y cell line (AB282566)
  • Sanger seq

Supplier Data

Sanger Sequencing - Human LMOD1 knockout SH-SY5Y cell line (AB282566)

Key facts

Cell type

SH-SY5Y

Species or organism

Human

Tissue

Bone marrow

Form

Liquid

form

Knockout validation

Sanger Sequencing

Disease

Neuroblastoma

Product details

Recommended control: Human wild-type SHSY-5Y cell line (ab275475). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab282566-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab282566 Human LMOD1 knockout SH-SY5Y cell line", "number":"AB282566-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LMOD1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • These cells grow as a mixture of floating and adherent cells.
  • Remove media containing floating cells and recover cells by centrifugation, detach cells using standard methods, combine with floating cells and transfer to a new culture flask.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be seeded at a density conducive to cell–cell communication to proliferate. If cells are seeded too sparsely, growth rate is reduced and cell death is high.
Culture medium

1:1 mixture of EMEM and F-12K + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LMOD1 also known as Leiomodin 1 is a protein involved in actin filament dynamics. It has a molecular mass of approximately 64 kDa. The protein plays a role in the regulation of actin nucleation and assembly which are critical for the structural integrity and function of muscle cells. LMOD1 is expressed in smooth muscle tissues including those in the vascular system. This expression highlights its functional significance in maintaining smooth muscle contractility.
Biological function summary

LMOD1 contributes to muscle cell contraction by stabilizing and organizing actin filaments. It functions by binding to the pointed ends of actin filaments and may form a part of a multiprotein complex with actin and other actin-binding proteins. This association enhances its capability to regulate actin filament growth and stability factors essential for maintaining cellular structure and motility in smooth muscle tissues. LMOD1's ability to influence actin filament dynamics highlights its significance in muscle cell function and integrity.

Pathways

LMOD1 impacts actin dynamics critical to the smooth muscle contraction pathway. It interacts with proteins such as tropomyosin and tropomodulin influencing actin filament stabilization and organization. The smooth muscle contraction pathway is essential for vascular tone and blood flow regulation. LMOD1's association with actin regulation aligns its role within this pathway impacting smooth muscle cellular contractility and overall smooth muscle function.

LMOD1 is associated with vascular diseases such as arteriosclerosis due to its role in smooth muscle function. Alterations in LMOD1 expression or mutations can lead to abnormal muscle contraction and vascular issues. Additionally LMOD1 has links to hypertensive conditions where dysregulated smooth muscle contraction affects blood pressure control. In these conditions LMOD1 interacts with proteins like actin and tropomyosin which play a role in cellular contractility and are critical in maintaining normal vascular function.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com